Pregnant and addicted: Treatment options safe for you and your baby

Substance use during pregnancy creates a painful dilemma: the person knows they need help, but fears that seeking treatment will result in losing custody, being reported to authorities, or harming the baby through withdrawal. These fears, while understandable, often delay treatment that is critical for both maternal and fetal health.

The safety of MAT during pregnancy

Every major medical organization — ACOG, SAMHSA, WHO, ASAM — recommends medication-assisted treatment (specifically buprenorphine or methadone) as the standard of care for pregnant women with opioid use disorder. Medically supervised MAT is safer for the fetus than continued illicit opioid use (which carries risks of overdose, infectious disease, and unpredictable fetal drug exposure) and safer than unsupervised withdrawal (which can cause fetal distress, preterm labor, and miscarriage). Buprenorphine (Subutex — the formulation without naloxone — is typically preferred during pregnancy) has been extensively studied and is considered safe during pregnancy and breastfeeding.

Neonatal Abstinence Syndrome

Babies born to mothers on MAT may experience Neonatal Abstinence Syndrome (NAS) — a treatable condition involving temporary withdrawal symptoms in the newborn. NAS is managed in the hospital with monitoring and, if necessary, short-term medication. While NAS sounds frightening, it is a known and manageable outcome that is far safer than the alternative risks of untreated opioid use during pregnancy. Buprenorphine is associated with shorter NAS duration and less severe symptoms compared to methadone.

Legal protections

Many women fear that disclosing substance use to healthcare providers will result in automatic child removal. Laws vary by state, but in most states, substance use during pregnancy alone does not constitute child abuse or neglect, MAT treatment is a sign of responsible prenatal care (not evidence against you), healthcare providers' primary obligation is to provide treatment (not to report to authorities), and family drug courts and treatment programs increasingly focus on keeping families together during recovery. ACOG explicitly opposes punitive approaches to substance use during pregnancy, stating that they deter people from seeking prenatal care.

Finding specialized care

Look for prenatal addiction programs that offer integrated obstetric and addiction care (so you are not navigating two separate systems), MAT with buprenorphine or methadone prescribed by providers experienced in perinatal addiction medicine, mental health support for the anxiety, shame, and trauma that often accompany substance use during pregnancy, and postpartum planning that addresses both recovery maintenance and newborn care.

Find treatment near you

Authoritative sources

This article references guidelines from: SAMHSA · NIDA · ASAM

Frequently asked questions

Disclaimer: Informational only. Not medical advice. SAMHSA: 1-800-662-4357.